JPH054080B2 - - Google Patents
Info
- Publication number
- JPH054080B2 JPH054080B2 JP3927884A JP3927884A JPH054080B2 JP H054080 B2 JPH054080 B2 JP H054080B2 JP 3927884 A JP3927884 A JP 3927884A JP 3927884 A JP3927884 A JP 3927884A JP H054080 B2 JPH054080 B2 JP H054080B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- reagent
- present
- pyruvate
- epimerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims description 39
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 26
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims description 19
- 108010081916 N-acetylhexosamine oxidase Proteins 0.000 claims description 14
- 108010084853 neuraminic acid aldolase Proteins 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 238000006911 enzymatic reaction Methods 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 238000000034 method Methods 0.000 description 30
- 239000003153 chemical reaction reagent Substances 0.000 description 29
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 20
- 229940076788 pyruvate Drugs 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 13
- 102000005348 Neuraminidase Human genes 0.000 description 9
- 108010006232 Neuraminidase Proteins 0.000 description 9
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 8
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 8
- 239000008363 phosphate buffer Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 4
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 4
- OVRNDRQMDRJTHS-OZRXBMAMSA-N N-acetyl-beta-D-mannosamine Chemical compound CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-OZRXBMAMSA-N 0.000 description 4
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 4
- -1 N-acetylneuraminic acid neuraminic acid Chemical compound 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229950006780 n-acetylglucosamine Drugs 0.000 description 4
- 229940107700 pyruvic acid Drugs 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108010042687 Pyruvate Oxidase Proteins 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-N cyanic acid Chemical compound OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- PHOLIFLKGONSGY-CSKARUKUSA-N (e)-(3-methyl-1,3-benzothiazol-2-ylidene)hydrazine Chemical compound C1=CC=C2S\C(=N\N)N(C)C2=C1 PHOLIFLKGONSGY-CSKARUKUSA-N 0.000 description 1
- UMPSXRYVXUPCOS-UHFFFAOYSA-N 2,3-dichlorophenol Chemical compound OC1=CC=CC(Cl)=C1Cl UMPSXRYVXUPCOS-UHFFFAOYSA-N 0.000 description 1
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 1
- HOLHYSJJBXSLMV-UHFFFAOYSA-N 2,6-dichlorophenol Chemical compound OC1=C(Cl)C=CC=C1Cl HOLHYSJJBXSLMV-UHFFFAOYSA-N 0.000 description 1
- KRNUKKZDGDAWBF-UHFFFAOYSA-N 2-(n-ethyl-n-m-toluidino)ethanol Chemical compound OCCN(CC)C1=CC=CC(C)=C1 KRNUKKZDGDAWBF-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- NZAVBNVWEPQSBL-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethoxyanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC(OC)=CC(OC)=C1 NZAVBNVWEPQSBL-UHFFFAOYSA-N 0.000 description 1
- STBWJPWQQLXSCK-UHFFFAOYSA-N 3-(n-ethyl-3-methoxyanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC=CC(OC)=C1 STBWJPWQQLXSCK-UHFFFAOYSA-N 0.000 description 1
- ZTQGWROHRVYSPW-UHFFFAOYSA-N 3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 ZTQGWROHRVYSPW-UHFFFAOYSA-N 0.000 description 1
- IBSUMVZKDLDAEK-UHFFFAOYSA-N 3-(n-ethyl-3-methylanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC=CC(C)=C1 IBSUMVZKDLDAEK-UHFFFAOYSA-N 0.000 description 1
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 1
- MOYHVSKDHLMMPS-UHFFFAOYSA-N 3-methoxy-n,n-dimethylaniline Chemical compound COC1=CC=CC(N(C)C)=C1 MOYHVSKDHLMMPS-UHFFFAOYSA-N 0.000 description 1
- CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- MNAOOJDHHBIBHD-YTMKKKKMSA-N CC(=O)C(O)=O.CC(=O)N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O Chemical compound CC(=O)C(O)=O.CC(=O)N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MNAOOJDHHBIBHD-YTMKKKKMSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- WSSMMNVKLQZMEF-BEKOLJTOSA-N N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O WSSMMNVKLQZMEF-BEKOLJTOSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 102000020006 aldose 1-epimerase Human genes 0.000 description 1
- 108091022872 aldose 1-epimerase Proteins 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- YQZKMBQLQRZWPA-UHFFFAOYSA-N benzene-1,3-diol;periodic acid Chemical compound OI(=O)(=O)=O.OC1=CC=CC(O)=C1 YQZKMBQLQRZWPA-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- CIPVVROJHKLHJI-UHFFFAOYSA-N n,n-diethyl-3-methylaniline Chemical compound CCN(CC)C1=CC=CC(C)=C1 CIPVVROJHKLHJI-UHFFFAOYSA-N 0.000 description 1
- ZPEDSBOBSNNATM-UHFFFAOYSA-N n-[2-(n-ethyl-3-methylanilino)ethyl]acetamide Chemical compound CC(=O)NCCN(CC)C1=CC=CC(C)=C1 ZPEDSBOBSNNATM-UHFFFAOYSA-N 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
本発明はN−アセチルノイラミン酸の酵素的定
量方法に関するものである。
生体内にはN−アセチルノイラミン酸の糖複合
体であるシアル酸が様々な形で存在する。このシ
アル酸は糖蛋白や樹脂質の重要な成分であり、臨
床検査の分野において急性および慢性炎症、シヨ
ク、外傷、心筋梗塞、糖尿病、肝疾患、各種癌等
で変動することが見い出されており、シアル酸測
定が診断に重要な役割を示めしている。
このシアル酸測定には化学法であるEhrlich法、
オルシノール法、レゾルシノール法、過ヨウ素酸
レゾシノール法、チオバルビツール酸法等が知ら
れているが、特異性に問題があつたり、中には強
酸を使用しなければならないもの、加熱操作を必
要とする等、操作が繁雑であるという欠点があつ
た。
酵素的測定法としてシアル酸をノイラミニダー
ゼでN−アセチルノイラミン酸を遊離させ、ノイ
ラミン酸アルドラーゼによりピルビン酸を生成
し、このピルビン酸を乳酸デヒドロゲナーゼ
(LDH)、NADH系で反応させ定量する方法、ピ
ルビン酸にピルビン酸オキシダーゼを作用させ生
ずる過酸化水素を定量する方法があるが、これら
の測定法は内因性ピルビン酸の影響を受けるとい
う欠点がある。
本発明者らは操作が簡単で、しかも内因性ピル
ビン酸の影響を受けない正確性の高いN−アセチ
ルノイラミン酸測定法を種々鋭意検討したとこ
ろ、試料にノイラミン酸アルドラーゼ、アシルグ
ルコサミン−2−エピメラーゼ(以下AG−エピ
メラーゼと略す)、N−アセチルヘキソサミンオ
キシダーゼ(以下NAHODと略す)の酵素を作
用させることにより、上記の目的が達成されるこ
とを見い出し本発明に到達した。
すなわち本発明はN−アセチルノイラミン酸の
試料にノイラミン酸アルドラーゼ、アシルグルコ
サミン−2−エピメラーゼ(AG−エピメラー
ゼ)およびN−アセチルヘキソサミンオキシダー
ゼ(NAHOD)を作用させて生成する過酸化水
素又はN−アセチルグルコサミン酸又は消費され
る酵素を測定することを特徴とするN−アセチル
ノイラミン酸の酵素的定量方法である。
本発明の測定原理は下記に示す通りである。
(A) 酵素反応
N−アセチルノイラミン酸ノイラミン酸アルドラーゼ
―――――――――――――→
N−アセチルマンノサミン+ピルビン酸
N−アセチルマンノサミンAG−エピメターゼ
――――――――――→
N−アセチルグルコサミン
N−アセチルグルコサミン+O2+H2ONAHOD
―――――――→
N−アセチルグルコサミン酸+H2O2
すなわちN−アセチルノイラミン酸をノイラミ
ン酸アルドラーゼによつてN−アセチルマンノサ
ミンとピルビン酸に分解し、生じたN−アセチル
マンノサミンにAG−エピメラーゼを作用させ、
N−アセチルグルコサミンを生成せしめる。この
N−アセチルグルコサミンに酸素と水の共存下、
NAHODを作用させることにより、N−アセチ
ルグルコサミン酸と過酸化水素を生じさせる。測
定方法はこの時生じる過酸化水素もしくはN−ア
セチルグルコサミン酸もしくは消費される酸素の
いずれかを測定することを特徴としている。
本発明に用いるノイラミン酸アルドラーゼとし
てはエシユリシア・コリ、クロストリデイウム
属、ラツトの肝、脳等から精製されるものがあ
り、いずれの起源によるものでも良いが、特に微
生物由来のものが好ましい。
本発明に用いるAG−エピメラーゼもいかなる
起源のものでも良いが、例えばゴーシユ、ロイゼ
マンによる「ジヤーナル・オブ・バイオロジカ
ル・ケミストリー」第24巻第4号第153頁に記載
されているブタの腎臓から精製したAG−エピメ
がある。このAG−エピメラーゼの反応を促進さ
せるためにはATPを添加しても良い。
本発明に用いるNAHODもいかなる起源のも
のでも良いが、例えば堀内による日本農芸化学会
昭和58年度大会講演要旨集第173頁に記載されて
いるシユードモナス属由来のNAHODがある。
必要があれば、このNAHODの反応を促進させ
るためにアノマーの変換を促進するムタロターゼ
を添加してもよい。
さらにノイラミニダーゼを作用させシアル酸を
測定する場合に使用するノイラミニダーゼは、い
かなる起源のものでも良いが、クロストリジウム
属、アルスロバクター属、コリネバクテリウム
属、ストレプトコツカス属等に属する微生物から
産生するものがある。
本発明で試料とは血清や血しよう、さらにはシ
アル酸を含む試料にノイラミニダーゼを作用させ
生成したN−アセチルノイラミン酸を含むものを
いう。
本発明で生成される過酸化水素の定量はいかな
る方法を用いても良いが、例えばペルオキシダー
ゼ、あるいはカタラーゼにより酵素法によつて比
色定量する方法、直接電極による定量方法などが
ある。
ペルオキシダーゼを用いる方法としては、色原
体として4−アミノアンチピリンとフエノールま
たはその誘導体、4−アミノアンチピリンとアニ
リンまたはその誘導体、3−メチル−2−ベンゾ
チアゾリノンヒドラゾンとアニリンまたはその誘
導体などを用いる方法がある。フエノール誘導体
としては、p−クロロフエノール、2,4−ジク
ロロフエノール、p−プロモフエノール、o−ク
ロロフエノール、m−クロロフエノール、2,6
−ジクロロフエノール、2,3−ジクロロフエノ
ールなどがある。またアニリン誘導体としては
N,N−ジメチルアニリン、N,N−ジエチルア
ニリン、N,N−ジエチル−m−トルイジン、
N,N−ジメチル−m−アニシジン、N−エチル
−N−(3−メチルフエニル)−N′−アセチルエ
チレンジアミン、N−エチル−N−(β−ヒドロ
キシエチル)−m−トルイジン、N−エチル−N
−(2−ヒドロキシ−3−スルホプロピル)−m−
トルイジン(以下EHSPTと略す)、N−エチル
−N−スルホプロピル−m−トルイジン、N−エ
チル−N−スルホプロピル−3,5−ジメトキシ
アニリン、N−エチル−N−(2−ヒドロキシ−
3−スルホプロピル)−3,5−ジメトキシアニ
リン、N−エチル−N−スルホプロピル−m−ア
ニシジン等がある。
カタラーゼを用いる方法としては、過酸化水素
とメタノールにカタラーゼを作用させ、生成した
ホルムアルデヒドをアンモニアの存在下、アセチ
ルアセトンと縮合させ、412nmの吸光度を測定
する方法がある。この方法は検体ブランクをとる
ことにより正確な濃度測定が行なえる。
酸素の消費量から定量する方法としては酸素電
極を用いて定量する方法がある。
又、本発明では過酸化水素の発色を妨害する検
体中のアスコルピン酸をアスコルビン酸オキシダ
ーゼ(以下ASOと略記する)を作用させること
により除去することもできる。この場合、ASO
は他の酵素反応に先だつて作用させても、また他
の酵素反応と共役させて同時に作用させて除去し
てもよい。ASOは微生物又は植物由来のものが
あるが、好ましくはカボチヤ、キユウリ由来のも
のがある。
本発明による試薬はPH3〜10に緩衝した組成物
であり、本発明による試薬を用いN−アセチルノ
イラミン酸を測定する場合の反応温度は約4〜50
℃である。
本発明によるN−アセチルノイラミン酸測定用
組成物はノイラミン酸アルドラーゼ、AG−エピ
メラーゼ、NAHODの酵素類、生成される過酸
化水素またはN−アセチルグルコサミン酸又は消
費される酸素を定量するための酵素類または試薬
類を適当に組み合わせることにより成る。この試
薬類、酵素類は液剤、固型剤もしくは凍結乾燥剤
とし、必要に応じて使用前に緩衝液を添加して測
定用試薬とする。
測定方法は試料にまずノイラミン酸アルドラー
ゼ、AG−エピメラーゼを作用させ、N−アセチ
ルノイラミン酸をN−アセチルマンノサミンに、
さらにN−アセチルグルコサミンとする。次に
NAHODおよび生成される過酸化水素を測定す
る試薬を作用させることにより過酸化水素を測定
する。本発明では測定方法は1試薬系でも2試薬
系でも良く、さらには何試薬系で測定しても良
い。
本発明では、試料にノイラミン酸アルドラー
ゼ、AG−エピメラーゼおよびNAHODを作用さ
せることにより、操作が簡単で、しかも内因性ピ
ルビン酸の影響を受けない正確性の高いN−アセ
チルノイラミン酸定量が可能となり、シアル酸の
臨床検査の診断分野においてもきわめて有意義で
ある。
次に本発明を実施例により説明する。
実施例 1
溶液中のN−アセチルノイラミン酸の濃度を下
記試薬を用い、下記方式により定量した。
1 試薬
ノイラミン酸アルドラーゼ 40単位
AG−エピメラーゼ 300μ
NAHOD 4単位
4−AA 0.5mg
EHSPT 2mg
ATP 60.53mg
0.1Mリン酸緩衝液(PH7.0) 全量10ml
2 測定方法
試料20μを試験管にとり、これに上記試薬
3mlを添加し、37℃20分間反応させた後、波長
550nmで吸光度測定した。この試料のN−ア
セチルノイラミン酸の濃度は既知濃度のN−ア
セチルノイラミン酸と比較することにより求め
た。第1図に検量線を示す。
実施例 2
血清中のシアル酸量を下記試薬を用い、下記方
法により定量した。
本発明の効果を説明するため、次のように試験
を行なつた。血清中のシアル酸にノイラミニダー
ゼを作用させ、N−アセチルノイラミン酸にし、
本発明の定量方法によつて測定する方法をA法と
する。血清中のシアル酸をノイラミニダーゼでノ
イラミン酸にし、ノイラミン酸アルドラーゼによ
りピルビン酸を生成し、このピルビン酸にピルビ
ン酸オキシダーゼを作用させ、生ずる過酸化水素
を定量する方法をB法とする。A、Bの方法で血
清中のシアル酸量を定量した。さらに同一の血清
中に存在するピルビン酸量をピルビン酸にピルビ
ン酸オキシダーゼを作用させ、生成する過酸化水
素を測定する方法を用い定量した。
A 法
1 試薬
ノイラミニダーゼ(半井化学製) 10単位
ノイラミン酸アルドラーゼ(半井化学製)
40単位
AG−エピメラーゼ 0.3ml
NAHOD 1単位
4−AA 0.5mg
EHSPT 2mg
ATP 60.53mg
0.1Mリン酸緩衝液(PH7.0) 全量10ml
2 測定方法
血清を20μ試験管に取り、上記試薬3mlを
添加し、37℃20分反応させた後、波長550nm
で吸光度測定した。血清中のシアン酸量は既知
濃度のシアル酸を比較することにより求めた。
B 法
スガワラ等による「クリニカ ヒミカ アク
タ」第108巻第493〜498頁に記載されている方法
で測定した。
1 試薬
試薬B
ノイラミニダーゼ(半井化学製) 2単位
ノイラミン酸アルドラーゼ(半井化学製)
10単位
6mMリン酸緩衝液(PH6.8) 全量10ml
試薬B 下記の試薬B− B−を容
量比5:2の割合に混合する。
B−
ピリビン酸オキシダーゼ 100単位
TPP 14μmole
FAD 0.36μmole
p−クロロフエノール 57μmole
MgCl2 150μmole
20mMリン酸緩衝液(PH7.4) 全量15ml
B−
POD 550単位
4−AA 89μmole
NaN3 1.55mmole
4mMリン酸緩衝液(PH7.0) 50ml
試薬B
EDTA 50mmole
Na2HPO4 0.1mole
クエン酸ナトリウム 0.1mole
トリトンX−405 3g
イオン交換水 全量1
2 測定方法
血清を50μ試験管にとり、これに試薬B
0.5mlを添加し、45℃30分間インキユベートし
た後、試薬B1mlを添加し、さらに15分間イ
ンキユベートし、試薬B3.5mlを添加し室温
で10分間放置した後、波長505nmで吸光度を
測定した。血清中のシアル酸量は既知濃度のシ
アル酸と比較することによつて求めた。
ピルビン酸濃度測定
1 試薬
試薬C 下記の試薬C− C−を容
量比5:2の割合に混合する。
試薬C−
ノイラミニダーゼ(半井化学製) 2単位
ノイラミン酸アルドラーゼ(半井化学製)
10単位
6mMリン酸緩衝液(PH6.8) 全量10ml
試薬C−
POD 550単位
4−AA 89μmole
NaN3 1.5mmole
4mMリン酸緩衝液(PH7.0) 50ml
試薬C
EDTA 50mM
NaN2HPO4 0.1mmole
クエン酸ナトリウム 0.1mole
トリトンX−405 3g
イオン交換水 全量1g
2 測定方法
血清を50μを試験管にとり、これに試薬C
1mlを添加し37℃15分間インキユベートした
後、試薬C3.5mlを添加し室温で10分間放置
した後、波長505nmで吸光度を測定した。血
清中のピルビン酸濃度は既知濃度のピルビン酸
と比較することによつて求めた。
血清中のシアル酸濃度、ピルビン酸濃度の測定
値を第1表に示す。
第1表には血清中のピルビン酸量をシアル酸濃
度に換算した値も記載する。
The present invention relates to a method for enzymatically quantifying N-acetylneuraminic acid. Sialic acid, which is a sugar complex of N-acetylneuraminic acid, exists in various forms in living organisms. This sialic acid is an important component of glycoproteins and resins, and in the field of clinical testing, it has been found that it changes in acute and chronic inflammation, shock, trauma, myocardial infarction, diabetes, liver disease, various cancers, etc. , sialic acid measurement has shown an important role in diagnosis. The Ehrlich method, which is a chemical method, is used to measure sialic acid.
Orcinol method, resorcinol method, periodate resorcinol method, thiobarbituric acid method, etc. are known, but they have problems with specificity, some require the use of strong acids, and some require heating operations. The disadvantage was that the operations were complicated. As an enzymatic measurement method, N-acetylneuraminic acid is released from sialic acid using neuraminidase, pyruvate is generated using neuraminic acid aldolase, and this pyruvate is reacted with lactate dehydrogenase (LDH) and NADH system to quantify pyruvate. There are methods for quantifying hydrogen peroxide produced by the action of pyruvate oxidase on acid, but these measurement methods have the drawback of being influenced by endogenous pyruvate. The present inventors have intensively investigated various methods for measuring N-acetylneuraminic acid that are easy to operate and are not affected by endogenous pyruvate and have found that neuraminic acid aldolase, acylglucosamine-2- The present invention has been achieved by discovering that the above object can be achieved by using the enzymes epimerase (hereinafter abbreviated as AG-epimerase) and N-acetylhexosamine oxidase (hereinafter abbreviated as NAHOD). That is, the present invention provides hydrogen peroxide or N-acetyl neuraminic acid produced by reacting a sample of N-acetylneuraminic acid with neuraminic acid aldolase, acylglucosamine-2-epimerase (AG-epimerase), and N-acetylhexosamine oxidase (NAHOD). This is an enzymatic method for quantifying N-acetylneuraminic acid, which is characterized by measuring glucosamic acid or consumed enzyme. The measurement principle of the present invention is as shown below. (A) Enzyme reaction N-acetylneuraminic acid neuraminic acid aldolase――――――――――――→ N-acetylmannosamine + pyruvate N-acetylmannosamine AG-epimetase―――― ――――――→ N-acetylglucosamine N-acetylglucosamine + O 2 + H 2 ONAHOD ――――――――→ N-acetylglucosaminic acid + H 2 O 2 , that is, N-acetylneuraminic acid, is converted to N-acetylglucosamine by neuraminic acid aldolase. Then, it is decomposed into N-acetylmannosamine and pyruvate, and the resulting N-acetylmannosamine is treated with AG-epimerase.
Produces N-acetylglucosamine. This N-acetylglucosamine in the coexistence of oxygen and water,
By acting with NAHOD, N-acetylglucosaminic acid and hydrogen peroxide are produced. The measuring method is characterized by measuring either hydrogen peroxide or N-acetylglucosamic acid produced at this time, or oxygen consumed. The neuraminic acid aldolase used in the present invention includes those purified from E. coli, Clostridium, rat liver, brain, etc., and may be derived from any source, but those derived from microorganisms are particularly preferred. The AG-epimerase used in the present invention may be of any origin, but for example, the AG-epimerase purified from pig kidney described in "Journal of Biological Chemistry" by Gauchiel and Roisemann, Vol. 24, No. 4, p. 153. There is an AG-epime. ATP may be added to promote this AG-epimerase reaction. The NAHOD used in the present invention may be of any origin, but for example, there is NAHOD derived from the genus Pseudomonas, which is described in Horiuchi's Proceedings of the 1981 Annual Conference of the Japanese Society of Agricultural Chemistry, page 173.
If necessary, mutarotase, which promotes conversion of anomers, may be added to promote this NAHOD reaction. Furthermore, the neuraminidase used to measure sialic acid by the action of neuraminidase may be of any origin, but is produced from microorganisms belonging to the genus Clostridium, Arthrobacter, Corynebacterium, Streptococcus, etc. There is. In the present invention, a sample refers to a sample containing N-acetylneuraminic acid produced by reacting neuraminidase to a sample containing serum, blood, or sialic acid. Any method may be used to quantify the hydrogen peroxide produced in the present invention, such as a colorimetric assay using an enzymatic method using peroxidase or catalase, and a method using a direct electrode. In the method using peroxidase, 4-aminoantipyrine and phenol or a derivative thereof, 4-aminoantipyrine and aniline or a derivative thereof, 3-methyl-2-benzothiazolinone hydrazone and aniline or a derivative thereof, etc. are used as a chromogen. There is a way. Examples of phenol derivatives include p-chlorophenol, 2,4-dichlorophenol, p-promophenol, o-chlorophenol, m-chlorophenol, 2,6
-dichlorophenol, 2,3-dichlorophenol, etc. Also, examples of aniline derivatives include N,N-dimethylaniline, N,N-diethylaniline, N,N-diethyl-m-toluidine,
N,N-dimethyl-m-anisidine, N-ethyl-N-(3-methylphenyl)-N'-acetylethylenediamine, N-ethyl-N-(β-hydroxyethyl)-m-toluidine, N-ethyl-N
-(2-hydroxy-3-sulfopropyl)-m-
Toluidine (hereinafter abbreviated as EHSPT), N-ethyl-N-sulfopropyl-m-toluidine, N-ethyl-N-sulfopropyl-3,5-dimethoxyaniline, N-ethyl-N-(2-hydroxy-
Examples include 3-sulfopropyl)-3,5-dimethoxyaniline, N-ethyl-N-sulfopropyl-m-anisidine, and the like. As a method using catalase, there is a method in which catalase is allowed to act on hydrogen peroxide and methanol, the resulting formaldehyde is condensed with acetylacetone in the presence of ammonia, and the absorbance at 412 nm is measured. This method allows accurate concentration measurements by taking a sample blank. As a method of quantifying oxygen consumption, there is a method of quantifying oxygen using an oxygen electrode. Furthermore, in the present invention, ascorbic acid in the specimen, which interferes with the color development of hydrogen peroxide, can be removed by the action of ascorbic acid oxidase (hereinafter abbreviated as ASO). In this case, ASO
may be removed by acting prior to other enzymatic reactions, or by conjugating with other enzymatic reactions and acting simultaneously. ASO may be derived from microorganisms or plants, preferably from pumpkin or cucumber. The reagent according to the present invention is a composition buffered at pH 3 to 10, and the reaction temperature when measuring N-acetylneuraminic acid using the reagent according to the present invention is about 4 to 50.
It is ℃. The composition for measuring N-acetylneuraminic acid according to the present invention is an enzyme for quantifying neuraminic acid aldolase, AG-epimerase, NAHOD enzymes, hydrogen peroxide produced or N-acetylglucosaminic acid, or oxygen consumed. or reagents by appropriately combining them. These reagents and enzymes are prepared as a liquid, solid, or lyophilized agent, and if necessary, a buffer solution is added before use to prepare a measurement reagent. The measurement method is to first treat the sample with neuraminic acid aldolase and AG-epimerase, converting N-acetylneuraminic acid to N-acetylmannosamine.
Furthermore, it is set as N-acetylglucosamine. next
Hydrogen peroxide is measured by reacting with NAHOD and a reagent that measures the hydrogen peroxide produced. In the present invention, the measurement method may be a one-reagent system or a two-reagent system, and may also be performed using any number of reagent systems. In the present invention, by allowing neuraminic acid aldolase, AG-epimerase, and NAHOD to act on the sample, it is possible to quantify N-acetylneuraminic acid with simple operation and high accuracy without being affected by endogenous pyruvate. It is also extremely meaningful in the diagnostic field of clinical testing for sialic acid. Next, the present invention will be explained by examples. Example 1 The concentration of N-acetylneuraminic acid in a solution was determined using the following reagent and the following method. 1 Reagent Neuramic acid aldolase 40 units AG-epimerase 300μ NAHOD 4 units 4-AA 0.5mg EHSPT 2mg ATP 60.53mg 0.1M phosphate buffer (PH7.0) Total volume 10ml 2 Measurement method Place 20μ of the sample in a test tube and add the above After adding 3 ml of reagent and reacting for 20 minutes at 37°C,
Absorbance was measured at 550 nm. The concentration of N-acetylneuraminic acid in this sample was determined by comparing it with a known concentration of N-acetylneuraminic acid. Figure 1 shows the calibration curve. Example 2 The amount of sialic acid in serum was determined using the following reagent and the following method. In order to explain the effects of the present invention, tests were conducted as follows. Neuraminidase acts on sialic acid in serum to convert it to N-acetylneuraminic acid,
The method of measurement using the quantitative method of the present invention is referred to as method A. Method B is a method in which sialic acid in serum is converted to neuraminic acid by neuraminidase, pyruvic acid is produced by neuraminic acid aldolase, pyruvate oxidase is allowed to act on this pyruvic acid, and the resulting hydrogen peroxide is quantified. The amount of sialic acid in serum was determined by methods A and B. Furthermore, the amount of pyruvate present in the same serum was quantified using a method in which pyruvate is reacted with pyruvate oxidase and the hydrogen peroxide produced is measured. A Method 1 Reagent neuraminidase (manufactured by Hanui Chemical) 10 units neuraminic acid aldolase (manufactured by Hanui Chemical)
40 units AG-epimerase 0.3ml NAHOD 1 unit 4-AA 0.5mg EHSPT 2mg ATP 60.53mg 0.1M phosphate buffer (PH7.0) Total volume 10ml 2 Measurement method Place serum in a 20μ test tube and add 3ml of the above reagent. , after reacting at 37℃ for 20 minutes, the wavelength was 550nm.
Absorbance was measured. The amount of cyanic acid in serum was determined by comparing known concentrations of sialic acid. B Method It was measured by the method described in "Clinica Himika Acta", Vol. 108, pp. 493-498 by Sugawara et al. 1 Reagent Reagent B Neuraminidase (manufactured by Hanui Chemical) 2 units neuraminic acid aldolase (manufactured by Hanui Chemical)
10 units 6mM phosphate buffer (PH6.8) Total volume 10ml Reagent B Mix the following reagent B-B- in a volume ratio of 5:2. B- Pyribate oxidase 100 units TPP 14μmole FAD 0.36μmole p-chlorophenol 57μmole MgCl 2 150μmole 20mM phosphate buffer (PH7.4) Total volume 15ml B- POD 550 units 4-AA 89μmole NaN 3 1.55mmole 4mM phosphate buffer (PH7.0) 50ml Reagent B EDTA 50mmole Na 2 HPO 4 0.1mole Sodium citrate 0.1mole Triton
After adding 0.5 ml and incubating at 45° C. for 30 minutes, adding 1 ml of reagent B and incubating for an additional 15 minutes, adding 3.5 ml of reagent B and standing at room temperature for 10 minutes, the absorbance was measured at a wavelength of 505 nm. The amount of sialic acid in serum was determined by comparing with known concentrations of sialic acid. Pyruvate concentration measurement 1 Reagent Reagent C Mix the following reagents C-C- at a volume ratio of 5:2. Reagent C- Neuraminidase (manufactured by Hanui Chemical) 2 units neuraminic acid aldolase (manufactured by Hanui Chemical)
10 units 6mM phosphate buffer (PH6.8) Total volume 10ml Reagent C- POD 550 units 4-AA 89μmole NaN 3 1.5mmole 4mM phosphate buffer (PH7.0) 50ml Reagent C EDTA 50mM NaN 2 HPO 4 0.1mmole Cigar Sodium chloride 0.1 mole Triton
After adding 1 ml and incubating at 37°C for 15 minutes, 3.5 ml of Reagent C was added and left at room temperature for 10 minutes, and then the absorbance was measured at a wavelength of 505 nm. Pyruvate concentration in serum was determined by comparing with known concentration of pyruvate. Measured values of sialic acid concentration and pyruvate concentration in serum are shown in Table 1. Table 1 also shows values obtained by converting the amount of pyruvate in serum into sialic acid concentration.
【表】【table】
【表】
第1表から明らかなように、従来法(B法)で
は血清中に存在するピルビン酸の影響を受け、シ
アル酸を過剰に定量するが、本発明ではピルビン
酸の影響を受けることなく、正確にシアル酸濃度
を定量することができる。[Table] As is clear from Table 1, in the conventional method (Method B), sialic acid is excessively determined due to the influence of pyruvic acid present in serum, but in the present invention, sialic acid is determined in excess due to the influence of pyruvic acid present in serum. The concentration of sialic acid can be determined accurately.
第1図は実施例1の検量線を示す。 FIG. 1 shows the calibration curve of Example 1.
Claims (1)
酸アルドラーゼ、アシルグルコサミン−2−エピ
メラーゼおよびN−アセチルヘキソサミンオキシ
ダーゼを作用させて、生成する過酸化水素又はN
−アセチルグルコサミン酸又は消費される酸素を
測定することを特徴とするN−アセチルノイラミ
ン酸の酵素的定量方法。1. Hydrogen peroxide or N produced by reacting neuraminic acid aldolase, acylglucosamine-2-epimerase and N-acetylhexosamine oxidase with N-acetylneuraminic acid sample
- An enzymatic method for quantifying N-acetylneuraminic acid, which comprises measuring acetylglucosaminic acid or consumed oxygen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3927884A JPS60184399A (en) | 1984-02-29 | 1984-02-29 | Method of enzymatic determination of n-acetylneuraminic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3927884A JPS60184399A (en) | 1984-02-29 | 1984-02-29 | Method of enzymatic determination of n-acetylneuraminic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60184399A JPS60184399A (en) | 1985-09-19 |
JPH054080B2 true JPH054080B2 (en) | 1993-01-19 |
Family
ID=12548696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3927884A Granted JPS60184399A (en) | 1984-02-29 | 1984-02-29 | Method of enzymatic determination of n-acetylneuraminic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60184399A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4960701A (en) * | 1986-12-04 | 1990-10-02 | Noda Institute For Scientific Research | N-acetylmannosamine dehydrogenase, process for its production, method for quantitatively analyzing N-acetylmannosamine or sialic acid, and kit for the quantitative analysis |
-
1984
- 1984-02-29 JP JP3927884A patent/JPS60184399A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60184399A (en) | 1985-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fossati et al. | Enzymic creatinine assay: a new colorimetric method based on hydrogen peroxide measurement. | |
CA1136027A (en) | Method for determining a substance in a biological fluid and reagent combination for use in the method | |
US4350762A (en) | Aminopyrine improved Trinder's reagent and dosing process for hydrogen peroxide from enzymatic oxidation of metabolic substrata with the same | |
US4245041A (en) | Triglycerides assay and reagents therefor | |
Matsubara et al. | Spectrophotometric determination of hydrogen peroxide with titanium 2-((5-bromopyridyl) azo)-5-(N-propyl-N-sulfopropylamino) phenol reagent and its application to the determination of serum glucose using glucose oxidase | |
Kohlbecker et al. | Direct spectrophotometric determination of serum and urinary oxalate with oxalate oxidase | |
EP0632133B1 (en) | Highly sensitive determination of d-3-hydroxybutyric acid or acetoacetic acid and composition therefor | |
EP0639646B1 (en) | High precision determination of d-glucose-6-phosphate and composition therefor | |
CN112255219A (en) | 1, 5-sorbitan determination kit, and preparation method and application thereof | |
JPH0771514B2 (en) | Method for quantifying 1,5-anhydroglucitol | |
JP2711721B2 (en) | Determination of 1,5-anhydroglucitol in samples containing glucose | |
EP0089210B1 (en) | Reagent for assaying cholinsterase | |
Gleeson et al. | A simple enzymatic fluorimetric method for the determination of branched-chain L-amino acids in microlitre volumes of plasma | |
JPH054080B2 (en) | ||
JPH08280399A (en) | Determination of trehalose or inorganic phosphorus | |
Bais et al. | Urinary glycolate measured by use of (S)-2-hydroxy-acid oxidase. | |
US4816394A (en) | Quantitative analysis of 3α-hydroxysteroid and reagent useful therefor | |
CS227331B2 (en) | Method of glycerol determination | |
JP3170320B2 (en) | Substance measurement method | |
EP0071087B1 (en) | Improved determination of creatine phosphokinase in body fluids | |
JPS60210998A (en) | Test composition, test kit and method for enzymatical measurement of inorganic phosphate | |
JP3034984B2 (en) | Highly sensitive method and composition for quantification of D-galactose | |
JP2885864B2 (en) | Determination of sialic acid | |
US4727025A (en) | Process and reagent for the fully enzymatic determination of urea | |
JP2761768B2 (en) | Method for determining NADH and method for determining bile acid using the same |